Cargando…
Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation
BACKGROUND: Proteomic-based discovery of biomarkers for disease has recently come under scrutiny for a variety of issues; one prominent issue is the lack of orthogonal validation for biomarkers following discovery. Validation by ELISA or Western blot requires the use of antibodies, which for many po...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019187/ https://www.ncbi.nlm.nih.gov/pubmed/21171974 http://dx.doi.org/10.1186/1479-5876-8-137 |